Latest News about ONCE
Recent news which mentions ONCE
Better Buy: Editas Medicine vs. CRISPR Therapeutics
December 27, 2019
From Motley Fool
A Perspective On Biopharma's Record M&A Run In 2019
December 23, 2019
From Benzinga
Is Editas Medicine a Buy?
December 18, 2019
From Motley Fool
From Benzinga
The Daily Biotech Pulse: Roche Gets US Antitrust Clearance For Spark Purchase, An Orphan Drug Designation For Prevail, Dynavax Names CEO
December 17, 2019
From Benzinga
European stocks struggle, with drugmakers weaker and Tullow Oil plunging
December 09, 2019
From MarketWatch
Here's Why uniQure Is Rallying 13% Today
December 03, 2019
From Motley Fool
The Gene Therapy Names Moving On The Audentes Buyout Deal
December 03, 2019
From Benzinga
Astellas’ $3 billion gene therapy deal steadies investors after stalled Roche acquisition
December 03, 2019
From MarketWatch
The Daily Biotech Pulse: Roche-Spark Deal Extended Again, Zymeworks' Positive Readout, Enanta Misses Earnings Estimate
November 22, 2019
From Benzinga
An early look at eFounders’ next batch of enterprise SaaS startups
November 07, 2019
Tickers
ONCE
From TechCrunch
The Daily Biotech Pulse: Mirati Tastes Success With KRAS Inhibitor, Roche-Spark Deal Delayed Further, Morphosys Halts Study
October 29, 2019
From Benzinga
8 Healthcare Stocks Moving In Tuesday's Pre-Market Session
October 22, 2019
From Benzinga
Tickers
ONCE
From MarketWatch
These battered biotech stocks are now buying opportunities as Elizabeth Warren climbs in the polls
October 11, 2019
From MarketWatch
Iovance Biotherapeutics: Buy the Dip?
August 27, 2019
From Motley Fool
CRISPR gene-editing technique set to push new boundaries
August 27, 2019
From MarketWatch
The Week Ahead In Biotech: Focus On Earnings Deluge, Mid-Year Clinical Trial Readouts
August 03, 2019
From Benzinga
The Daily Biotech Pulse: Roche-Spark Deal Faces Further Delay, Bayer's Prostate Cancer Drug Passes FDA Muster
July 31, 2019
From Benzinga
From Benzinga
Here's Why Sangamo Therapeutics Is Surging Today
July 08, 2019
From Motley Fool
What Drove uniQure 171% Higher in the First Half of 2019
July 08, 2019
From Motley Fool
The 5 Most Expensive Drugs In US: What You Should Know
June 23, 2019
From Benzinga
52 Biggest Movers From Yesterday
June 11, 2019
From Benzinga
From Motley Fool
Roche Extends Deadline For Spark Acquisition As US, UK Regulators Seek Additional Information
June 10, 2019
From Benzinga
30 Stocks Moving In Monday's Mid-Day Session
June 10, 2019
From Benzinga
24 Stocks Moving In Monday's Pre-Market Session
June 10, 2019
From Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.